24-hour service hotline：400-0858-856
On July 19, 2023, the Ministry of Industry and Information Technology and the State Medical Products Administration announced the "Biomedical Materials Innovation Task Unveiling Unit (the first batch) shortlisted unveiling unit". The key material project led by Zhejiang Zhongzin Medical Technology Co., LTD. Ethyl ester - ε-caprolactone copolymer material and its application project was successfully shortlisted with core technical advantages and industrial basic capabilities. The project, jointly declared by Zhejiang Zhongzin Medical Technology Co., Ltd. and Chengdu Organic Chemistry Co., LTD., Chinese Academy of Sciences, aims to "fill the international gap from basic research to product development, to clinical application and industrialization."
On August 10, Yiwu Finance Office and the Investment Banking Department of Haitong Securities Headquarters visited Zhongin Medical for guidance and exchange.Mr. Wang highly affirmed the company's achievements in material research and development innovation and device development, and also praised the company's chairman's strategic planning on industrial layout planning, and gave valuable guidance in combination with the current IPO situation.
On August 5th, Ying Songmin, Vice President of the Fourth Affiliated Hospital of Zhejiang University School of Medicine, visited our company and had in-depth exchanges on the cooperation in multiple fields between Zhongzai and Zhejiang Fourth Hospital.
On August 4-6, 2023, I participated in BIOCHINA2023,BIOCHINA Shanghai International Expo Center, the medical father. The exhibits of BioChina covered various new products, technologies and innovations needed for the production and processing of biological fermentation, biotechnology, medicine, biopharmaceuticals, bioengineering, biochip, microfluidic, confocal, cell engineering, genetic engineering, biopharmaceuticals, food, beer and beverages, biochemical engineering and biofeeds.The exhibition aims to build a whole industrial chain integrating "exhibition, commerce, learning and communication" and is committed to a one-stop solution for intelligent manufacturing in biotechnology industry.Booth information: Hall E6, Booth D71-2
The course of Chapter 1-3 of Amoeba Management Practice was held in the reading club, and the main content was the concept and purpose of Amoeba management.During the course, everyone actively discussed and expressed their feelings in combination with their own work and life.In the summary of the class, we learned that the structural efficiency is greater than the operational efficiency, which fully embodies that a good system is far better than the rule of man, and also fully embodies the necessity of adopting amoeba management.
On July 11-13, 2023, Zhongzai Medical went to Shanghai to attend analytica china.The booth of zhongzai Medical has attracted many industry peers and professional customers at home and abroad to consult and communicate.The R&D team of zhongzai Medical also took this opportunity to learn about industry consultation and broaden their horizons and punch in as a souvenir..
The 11th analytica China in Munich will be held at 8.2H, 1.2H and 2.2H in the National Convention and Exhibition Center (Shanghai) on July 11-13, 2023.Understand the heart of science and technology and explore the world! Zhongzhai Medical will present its new products at booth A528 of 8.2H Hall, and sincerely invite all friends to come.
Monday to Sunday 8:30-20:00
（Welcome to inquire）
Online service before, during and after sales
The Public
Tik Tok
